{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:07:33Z","timestamp":1791918453676,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejogrb.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:11:50Z","timestamp":1631229110000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["OBGYN practice patterns regarding combination therapy for prevention of preterm birth: A national survey"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-069X","authenticated-orcid":false,"given":"Whitney A.","family":"Booker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0384-8328","authenticated-orcid":false,"given":"Eda G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-3528","authenticated-orcid":false,"given":"Michael L.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Schulkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gyamfi-Bannerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2465-6747","authenticated-orcid":false,"given":"Tracy","family":"Manuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Berghella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2021.09.003_b0005","first-page":"1","article-title":"Births: Final Data for 2015. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics","volume":"66","author":"Martin","year":"2017","journal-title":"Nat Vital Statistics Syst"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.09.003_b0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.semperi.2009.06.007","article-title":"Prediction of preterm birth: cervical sonography","volume":"33","author":"Mella","year":"2009","journal-title":"Semin Perinatol"},{"issue":"9","key":"10.1016\/j.ejogrb.2021.09.003_b0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network","volume":"334","author":"Iams","year":"1996","journal-title":"New Engl J Med"},{"issue":"24","key":"10.1016\/j.ejogrb.2021.09.003_b0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"New Engld J Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.09.003_b0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.09.003_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstetrics Gynecol"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0035","doi-asserted-by":"crossref","unstructured":"Final report of the Medical Research Council\/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC\/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol 1993;100:516-23.","DOI":"10.1111\/j.1471-0528.1993.tb15300.x"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0040","doi-asserted-by":"crossref","unstructured":"Owen J, Hankins G, Iams JD, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstetrics Gynecol 2009;201:375.e1-8.","DOI":"10.1016\/j.ajog.2009.08.015"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.09.003_b0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.semperi.2009.06.008","article-title":"Alternative treatment for a short cervix: the cervical pessary","volume":"33","author":"Dharan","year":"2009","journal-title":"Semin Perinatol"},{"issue":"9828","key":"10.1016\/j.ejogrb.2021.09.003_b0050","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(12)60030-0","article-title":"Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial","volume":"379","author":"Goya","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0055","doi-asserted-by":"crossref","unstructured":"Practice bulletin no. 130: prediction and prevention of preterm birth. Obstetr Gynecol 2012;120:964-73.","DOI":"10.1097\/AOG.0b013e3182723b1b"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0060","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. Obstetr Gynecol 2008;112:963-5.","DOI":"10.1097\/AOG.0b013e31818b1ff6"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.09.003_b0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajog.2008.12.035","article-title":"Progesterone for preterm birth prevention: an evolving intervention","volume":"200","author":"Tita","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.09.003_b0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstetrics Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.09.003_b0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/uog.7547","article-title":"Effectiveness of cerclage according to severity of cervical length shortening: a meta-analysis","volume":"35","author":"Berghella","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/AOG.0b013e31820ca847","article-title":"Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis","volume":"117","author":"Berghella","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0085","doi-asserted-by":"crossref","unstructured":"Berghella V, Figueroa D, Szychowski JM, et al. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obst Gynecol 2010;202:351.e1-6.","DOI":"10.1016\/j.ajog.2010.02.019"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0031-1272967","article-title":"The effect of 17alpha-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage","volume":"28","author":"Rafael","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0095","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3109\/14767058.2012.717128","article-title":"Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-alpha-hydroxyprogesterone caproate","volume":"25","author":"Szychowski","year":"2012","journal-title":"The J Maternal-fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0100","first-page":"323","article-title":"Emergent cerclage","volume":"170","author":"Barth","year":"1990","journal-title":"Surgery, Gynecol Obstetrics"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0105","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00404-015-3772-4","article-title":"To do or not to do emergency cervical cerclage (a rescue stitch) at 24\u201328 weeks gestation in addition to progesterone for patients coming early in labor? A prospective randomized trial for efficacy and safety","volume":"292","author":"Ragab","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"10.1016\/j.ejogrb.2021.09.003_b0110","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/jog.13128","article-title":"Addition of adjuvant progesterone to physical-exam-indicated cervical cerclage to prevent preterm birth","volume":"42","author":"Jung","year":"2016","journal-title":"J Obstetrics Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0115","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstetrics Gynecol 2014;123:372\u20139.","DOI":"10.1097\/01.AOG.0000443276.68274.cc"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0032-1332799","article-title":"Effectiveness of 17-alpha-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage","volume":"30","author":"Mackeen","year":"2013","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.09.003_b0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/14767058.2017.1280019","article-title":"Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?","volume":"31","author":"Sinkey","year":"2018","journal-title":"J Maternal-fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/jpm-2017-0074","article-title":"Adjuvant administration of 17-alpha-hydroxy-progesterone caproate in women with three or more second trimester pregnancy losses undergoing cervical cerclage is no more effective than cerclage alone","volume":"46","author":"Samson","year":"2018","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0000000000001681","article-title":"Outcomes with cerclage alone compared with cerclage plus 17alpha-hydroxyprogesterone caproate","volume":"128","author":"Stetson","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.09.003_b0140","doi-asserted-by":"crossref","unstructured":"Stricker N, Timmesfeld N, Kyvernitakis I, Goerges J, Arabin B. Vaginal progesterone combined with cervical pessary: a chance for pregnancies at risk for preterm birth? Am J Obstetrics Gynecol 2016;214:739.e1\u2013e10.","DOI":"10.1016\/j.ajog.2015.12.007"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:53:28Z","timestamp":1759557208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521004474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"alternative-id":["S0301211521004474"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.09.003","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OBGYN practice patterns regarding combination therapy for prevention of preterm birth: A national survey","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}